BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 15, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Plan for long haul, analyst warns: Vital Therapies files $86M IPO; cycle 'sure to turn,' but when?

Oct. 16, 2013
By Randy Osborne

HIT roundup: ABILITY Network renewed for full accreditation from EHNAC

Oct. 16, 2013

Deals roundup: Brookhaven signs letter of intent to acquire WMT

Oct. 16, 2013

Med Tech Notes

Oct. 16, 2013

Product Briefs

Oct. 16, 2013

People in the News

Oct. 16, 2013

MDD's Oncology Extra

Oct. 16, 2013

Cleveland Clinic Medical Innovation Summit: Daschle: Those who defend status quo won't survive

Oct. 16, 2013
By Amanda Pedersen
Transformation has been the underlying theme of this year's Cleveland Clinic Medical Innovation Summit, beginning with the New Venture Healthcare Challenge on Monday (Medical Device Daily, Oct. 15, 2013) and continuing through former Sen. Tom Daschle's talk at dinner. Daschle told the roughly 1,500 Summit attendees that this country is on the brink of a historic transformation that, over the next decade, will change the healthcare landscape dramatically.
Read More

Amulyte takes Crowd Funding route to get device to market

Oct. 16, 2013
By Omar Ford
So just what can a med-tech start-up do to secure funding in a time where venture capital investors are extremely conservative with investment dollars? Why go to Crowd Investing of course.
Read More

Product Briefs

Oct. 15, 2013
Previous 1 2 … 3414 3415 3416 3417 3418 3419 3420 3421 3422 … 10250 10251 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing